Two cancer experts go head to head, arguing the case for and against a targeted prostate cancer screening programme.
A team led by Neil King, a biochemistry professor at the University of Washington School of Medicine, is now exploring a new ...
Consumers have testing options beyond the once-a-decade colonoscopy. But some doctors question Cologuard's testing program.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback